The 2nd TPD 2019 is a specifically dedicated scientific and networking forum for large pharma, innovative biotech and research institutes to capitalize on the emerging therapeutic class of protein degradation.
As the drug discovery opportunity promised within the proteome becomes a reality and previously "undruggable" targets are reached, the 2nd TPD Summit returns for 2019.
This premier event exists not only to drive forward the translation of first generation of PROTACS and molecular glues into the clinic, but to stimulate the discussion of next generation protein degraders that harness different modalities, target highly desirable targets and capitalize on degradation pathways, beyond the ubiquitin proteasome system.
As the drug discovery opportunity promised within the proteome becomes a reality and previously "undruggable" targets are reached, the 2nd TPD Summit returns for 2019.
This premier event exists not only to drive forward the translation of first generation of PROTACS and molecular glues into the clinic, but to stimulate the discussion of next generation protein degraders that harness different modalities, target highly desirable targets and capitalize on degradation pathways, beyond the ubiquitin proteasome system.
